Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106121.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Disability Evaluation
Europe
Female
Fibrinolytic Agents
Hospital Mortality
Humans
Infusions, Intravenous
Intracranial Hemorrhages
Iran
Male
Middle Aged
Risk Assessment
Risk Factors
Thrombolytic Therapy
Time Factors
Treatment Outcome

authors with profiles

James Siegler